Modifiable and nonmodifiable risk factors for non-ventilator-associated hospital-acquired pneumonia identified in a retrospective cohort study

被引:1
|
作者
Kachalov, Viacheslav N. [1 ,2 ]
Kuster, Stefan P. [1 ,2 ,3 ,4 ]
Balakrishna, Suraj [1 ,2 ]
Schreiber, Peter W. [1 ,2 ]
Jakob, Werner [5 ]
Sax, Hugo [1 ,2 ,6 ,7 ]
Kouyos, Roger D. [1 ,2 ]
Wolfensberger, Aline [1 ,2 ,8 ,9 ]
机构
[1] Univ Zurich, Univ Hosp Zurich, Div Infect Dis, Zurich, Switzerland
[2] Univ Zurich, Univ Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland
[3] Cantonal Hosp St Gallen, Hosp Epidemiol, St Gallen, Switzerland
[4] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland
[5] Univ Hosp Zurich, Dept Med Data Management Syst, ICT Directorate, Zurich, Switzerland
[6] Bern Univ Hosp, Dept Infect Dis, Bern, Switzerland
[7] Univ Bern, Bern, Switzerland
[8] Univ Zurich, Univ Hosp Zurich, Hosp Epidemiol, Ramistr 100, CH-8091 Zurich, Switzerland
[9] Univ Zurich, Univ Hosp Zurich, Div Infect Dis, Ramistr 100, CH-8091 Zurich, Switzerland
关键词
Healthcare-associated infections; Hospital-acquired pneumonia; Infection prevention; Pneumonia; Risk factors; CARE-ASSOCIATED INFECTIONS; NOSOCOMIAL PNEUMONIA; METAANALYSIS; PREVENTION; DIAGNOSIS; STROKE; DYSPHAGIA; PROGRAM;
D O I
10.1016/j.cmi.2022.05.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Hospital-acquired pneumonia in nonventilated patients (nvHAP) belongs to the most common healthcare-associated infections. This study aimed to investigate risk factors for nvHAP in patients outside the intensive care unit, focusing on modifiable risk factors. Methods: All inpatients admitted to an academic teaching hospital in Switzerland between 2017 and 2018 were included. nvHAP was defined according to European Centre for Disease Prevention and Control criteria. Patient days during and after ICU stay were excluded. Candidate risk factors-both constant and time varying-were included in uni- and multivariable Cox proportional hazards models. The decay ratio and the characteristic time of influence of hazard ratios (HRs) was estimated by adopting a linear decay in the Cox model. Results: A total of 66 001 hospitalizations with 314 (0.48%) nvHAP and 471 401 patient days were included. Median age was 57 years (interquartile range: 38 to 71 years) and 32 253 (48.9%) patients were male. Among nonmodifiable risk factors, age (adjusted HR (aHR) 2.66 for age >= 60 years, 95% CI 1.59 to 4.45) and male sex (aHR 1.71, 95% CI 1.34 to 2.18) were independently associated with nvHAP. Time-varying exposures showing strongest independent association with nvHAP were tube feeding (aHR 3.24, 95% CI 2.17 to 4.83), impaired consciousness (aHR 2.32, 95% CI 1.63 to 3.31), and severely impaired activity and mobility (aHR 2.06, 95% CI 1.50 to 2.84). The association with nvHAP decayed within 7.1 to 13.2 days after these exposures ended. Discussion: The risk for nvHAP varies with time, depending on the patient's medical condition and medical interventions. Several risk factors for nvHAP represent potential targets for specific prevention measures. (C) 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1451 / 1457
页数:7
相关论文
共 50 条
  • [1] Progress in preventing non-ventilator-associated hospital-acquired pneumonia
    Klompas, Michael
    [J]. LANCET INFECTIOUS DISEASES, 2023, 23 (07): : 769 - 771
  • [2] Intervention to reduce the incidence of non-ventilator-associated hospital-acquired pneumonia: A pilot study
    Sopena, Nieves
    Isernia, Valentina
    Casas, Irma
    Diez, Beatriz
    Guasch, Ignasi
    Sabria, Miquel
    Pedro-Botet, Maria Luisa
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (12) : 1324 - 1328
  • [3] Strategies to reduce non-ventilator-associated hospital-acquired pneumonia: A systematic review
    Mitchell, Brett G.
    Russo, Philip L.
    Cheng, Allen C.
    Stewardson, Andrew J.
    Rosebrock, Hannah
    Curtis, Stephanie J.
    Robinson, Sophia
    Kiernan, Martin
    [J]. INFECTION DISEASE & HEALTH, 2019, 24 (04) : 229 - 239
  • [4] Adverse Outcomes of Patients with Non-Ventilator-Associated Hospital-Acquired Pneumonia (nvHAP)-A Single Centre Cohort Study
    Amodio, Enrica
    Schreiber, Peter W.
    Hesse, Mirjam Faes
    Wolfensberger, Aline
    [J]. INFECTIOUS DISEASE REPORTS, 2024, 16 (02) : 228 - 238
  • [5] Comprehensive Oral Care to Prevent Non-Ventilator-Associated Hospital-Acquired Pneumonia
    Quinn, B.
    Baker, D.
    Parise, C.
    [J]. CLINICAL NURSE SPECIALIST, 2013, 27 (02) : E15 - E16
  • [6] The incidence, characteristics and in-hospital mortality of non-ventilator-associated hospital-acquired pneumonia in regional Queensland: A retrospective descriptive study
    Gardiner, Wenonah
    Brown, Kassandra
    Richardson, Heather
    Pretorius, Nellie
    Heales, Luke
    [J]. AUSTRALIAN JOURNAL OF RURAL HEALTH, 2023, 31 (01) : 138 - 143
  • [7] Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia
    Rubinstein, Ethan
    Stryjewski, Martin E.
    Barriere, Steven L.
    [J]. INFECTION AND DRUG RESISTANCE, 2014, 7 : 129 - 135
  • [8] NON-VENTILATOR-ASSOCIATED HOSPITAL-ACQUIRED PNEUMONIA: CLINICAL AND PROJECTED FINANCIAL IMPACTS IN AUSTRALIA
    Tan, J.
    Geake, J.
    Lau, K.
    Gibney, A.
    Wu, X.
    [J]. RESPIROLOGY, 2019, 24 : 192 - 192
  • [9] Hospitalizations for Community-Acquired and Non-Ventilator-Associated Hospital-Acquired Pneumonia in Spain: Influence of the Presence of Bronchiectasis. A Retrospective Database Study
    Sanchez-Munoz, Gema
    Lopez-de-Andres, Ana
    Hernandez-Barrera, Valentin
    Pedraza-Serrano, Fernando
    Jimenez-Garcia, Rodrigo
    Lopez-Herranz, Marta
    Puente-Maestu, Luis
    de Miguel-Diez, Javier
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 14
  • [10] A Retrospective Study of Non-Ventilator-Associated Hospital Acquired Pneumonia Incidence and Missed Opportunities for Nursing Care
    Tesoro, Mary
    Peyser, Diane J.
    Villarente, Farley
    [J]. JOURNAL OF NURSING ADMINISTRATION, 2018, 48 (05): : 285 - 291